{"disease":{"id":"lyme-borreliosis","name":"lyme borreliosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06835075","title":"Clinicaly Manifested Reinfections with Borrelia Burgdorferi Sensu Lato","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":15000,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false},{"nct_id":"NCT01504347","title":"Phase 1/2 Lyme Vaccine Study","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":1630,"lead_sponsor_name":"Baxalta now part of Shire","has_results":false},{"nct_id":"NCT04031469","title":"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease","phase":"","overall_status":"SUSPENDED","enrollment_count":1000,"lead_sponsor_name":"ProgenaBiome","has_results":false},{"nct_id":"NCT04801420","title":"Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study Population","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":625,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03769194","title":"Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":572,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03873974","title":"Performance Evaluation of the DualDur In Vitro Diagnostic System in the Diagnosis of Lyme Borreliosis","phase":"","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Lyme Diagnostics Ltd.","has_results":false},{"nct_id":"NCT03970733","title":"Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":246,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06929546","title":"Anti-phospolipid Antibodies in Lyme Borreliosis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":240,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false},{"nct_id":"NCT07226882","title":"A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":207,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT03010228","title":"Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":179,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT07230028","title":"Doxycycline Boosted Therapy in Lyme Borreliosis: DoBo Study.","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04577053","title":"PEMF Therapy to Treat Lingering Symptoms of Lyme Disease After Treatment With Antibiotics","phase":"NA","overall_status":"TERMINATED","enrollment_count":20,"lead_sponsor_name":"Kasey Phifer","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}